REG - Schroders Cap Glbl - Sale of Bluewater Bio Limited

Schroders Capital Global Innovation TrustAnnouncement

20/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260120:nRST4971Pa&default-theme=true

RNS Number : 4971P  Schroders Capital Gbl Inn Tst PLC  20 January 2026

Schroders Capital Global Innovation Trust plc

Sale of Bluewater Bio Limited

 

Schroders Capital Global Innovation Trust plc (the "Company" or "INOV") is
pleased to announce that its holding of the Salica Environmental Technology
Fund ("SETF"), previously HP Environmental Technologies Fund LP ("HPET"), has
completed the sale of its underlying portfolio company, Bluewater Bio Limited
("Bluewater Bio") to a European PE backed strategic acquiror. The expected
distributions from the exit are in line with the valuation indicated in the
Company's Q3 2025 NAV and, subject to confirmation of timing, the Manager does
not expect the transaction to result in any material change to the Company's
most recently published NAV.

In December 2020, the Portfolio Manager structured an option to allow the
Company to retain exposure to the underlying portfolio of Ombu Group Limited
("Ombu") and its future value creation potential, whereby the Company elected
to contribute its shareholding in Ombu in return for a partnership interest in
HPET.

This latest sale is part of the ongoing process of selling the assets and wind
down of the Company that began in February 2025. It is the Board's intention
to make a further return of capital to shareholders later this year,
reflecting the realisations, including this one, up to that point. To receive
email notifications from the Company in relation to distributions of capital
to shareholders, please register using the following link:
https://www.schroders.com/inovcomms (https://www.schroders.com/inovcomms)

All unquoted holdings, including the impact of this transaction, will be
reviewed and finalised as part of the Company's FY25 Annual Report and
Accounts.

Tim Creed, Lead Portfolio Manager, and Harry Raikes, Co-Portfolio Manager
commented: "We would like to congratulate the management teams at Bluewater
Bio and Salica on this transaction. The acquisition represents one of the
final exits from SETF generating a total multiple of invested capital from the
fund of 2.8x, with the potential to increase to 2.9x with the full impact of
potential earnouts. As a ~5% holding, this exit is a significant realisation
event for INOV, with a distribution of £6.5m due to the Company as part of
the wind down approved by shareholders in 2025."

 

Enquiries:

Schroder Investment Management Limited

Francesca Davis / Katherine Fyfe (Company Secretary)         020 7658
6000

Charlotte Banks / Kirsty Preston
(PR)
020 7658 6000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DISGPUAGGUPQGMB



            Copyright 2019 Regulatory News Service, all rights reserved